Log In
BCIQ
Print this Print this
 

NOV110501

  Manage Alerts
Collapse Summary General Information
Company National OncoVenture
DescriptionHumanized IgG4 antibody targeting hepatocyte growth factor (HGF)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationLeiomyosarcoma
Indication DetailsTreat leiomyosarcoma (LMS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today